Business intelligence for bio/pharma drugs – DrugPatentWatch
- All prices mentioned above are in United States dollar.
- This product is available at Udemy.
- At udemy.com you can purchase Business intelligence for bio/pharma drugs - DrugPatentWatch for only $44.99
- The lowest price of Business intelligence for bio/pharma drugs - DrugPatentWatch was obtained on December 15, 2024 11:50 pm.
$44.99 Original price was: $44.99.$10.00Current price is: $10.00.
Best deal at: udemy.com
Buy for best price
Set Lowest Price Alert
×
Notify me, when price drops
Set Alert for Product: Business intelligence for bio/pharma drugs - DrugPatentWatch - $44.99
Price history
×
Price history for Business intelligence for bio/pharma drugs - DrugPatentWatch | |
---|---|
Latest updates:
|
|
Add to wishlistAdded to wishlistRemoved from wishlist 0
Business intelligence for bio/pharma drugs – DrugPatentWatch
$44.99 Original price was: $44.99.$10.00Current price is: $10.00.
Description
Price history for Business intelligence for bio/pharma drugs - DrugPatentWatch | |
---|---|
Latest updates:
|
|
Didn't find the right price? Set price alert below
Set Alert for Product: Business intelligence for bio/pharma drugs - DrugPatentWatch - $44.99
Business intelligence for bio/pharma drugs - DrugPatentWatch
★★★★★
$44.99
in stock
Udemy.com
as of December 15, 2024 11:50 pm
Transform Data into Market Domination -- Finding and Evaluating Generic and Branded Drug Opportunties (FREE TEXTBOOK)
Created by:
Yali Friedman, Ph.D.
Publisher, DrugPatentWatch
Publisher, DrugPatentWatch
Rating:4.34 (107reviews)
469students enrolled
What Will I Learn?
- Finding and evaluating generic drug market entry opportunities
- Branded drug lifecycle management
- Find generic drug entry opportunities
- Track drugs in development and explore new indications for existing drugs
- Study failed patent challenges to develop a better strategy
- Collect competitive intelligence by examining contractual disputes
- Track litigation to anticipate early generic entry
- Find and evaluate business opportunities
- Assess levels of generic competition
- Use drug price ranges to evaluate price elasticity
- Determine optimal prices before launch
- Evaluate buyer power with data on reimbursement segmentation
- Align distribution methods with information on where and how drugs are purchased
- Evaluate branded and generic market opportunities globally
- Anticipate 505(b)(2) and biosimilar approvals
- Strengthen new formulation patents by studying prior claims and litigation
- Adapt your gmp facility to capture changes in demand with brand erosion and generic launches as drug patents expire
- Position regulatory affairs to capture emerging opportunities
- Understand the roles of patents, trade secrets, trademark, and other forms of intellectual property protection in protecting branded pharmaceutical and biotechnology drugs
- Proactively adapt sourcing, purchasing, and supply chain management to anticipate changes in supply and demand with generic drug entry
Requirements
- basic understanding of the pharmaceutical industry
Target audience
- Generic pharmaceutical company portfolio managers
- Branded drug lifecycle management, sourcing, procurement, and supply chain professionals
- Pharmaceutical drug analysts, investment analysts, and patent analysts
- Patent analysts
- Patent Landscape Profilers
- Biotech and Pharma Investors
- Supply chain, sourcing, purchasing managers, procurement, wholesalers, distributors, and warehouses
- Good Manufacturing Practice (GMP) facility owners and operators
- Pharmaceutical regulatory affairs professionals, lawyers, consultants, and founders
- Drug and medical device development managers
Price History
Price history for Business intelligence for bio/pharma drugs - DrugPatentWatch | |
---|---|
Latest updates:
|
|
Reviews (0)
User Reviews
0.0 out of 5
★★★★★
0
★★★★★
0
★★★★★
0
★★★★★
0
★★★★★
0
Write a review
There are no reviews yet.